Rockefeller Capital Management
ORGO icon

Rockefeller Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Rockefeller Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.45K Sell
3,067
-3,420
-53% -$8.36K ﹤0.01% 4123
2026
Q1 		$15.4K Buy
6,487
+5,186
+399% +$18K ﹤0.01% 3818
2025
Q4 		$6.74K Buy
+1,301
New +$6.3K ﹤0.01% 3965
2023
Q1 		– Sell
-38
Closed – – 3297
2022
Q4 		$0 Hold
38
– – ﹤0.01% 4115
2022
Q3 		$0 Buy
+38
New +$172 ﹤0.01% 4246

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Rockefeller Capital Management's ORGO Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Organogenesis Holdings (ORGO) stake by 53% in Q2 2026, selling an estimated $8.36K and leaving 3,067 shares worth $7.45K. The position accounts for ﹤0.01% of the portfolio, ranked #4123.

Rockefeller Capital Management first reported a position in ORGO in Q3 2022 and has held it in 5 quarters since. The position peaked at $15.4K in Q1 2026. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Rockefeller Capital Management held 3,067 shares of Organogenesis Holdings worth $7.45K as of Q2 2026.
  • Rockefeller Capital Management sold 3,420 Organogenesis Holdings shares in Q2 2026, an estimated $8.36K.
  • Organogenesis Holdings made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4123 holding.
  • Rockefeller Capital Management first reported a position in Organogenesis Holdings in Q3 2022 and has held it in 5 quarters since.
  • Rockefeller Capital Management's Organogenesis Holdings position peaked at $15.4K in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.